KALLOS AS
Operating
Tilby hudbehandlinger innen kosmetisk dermatologisk medisin. Fokus
blir å øke bevissthet og kunnskap om hudhelse blant befolkningen, og
forebygging av ulike hudtilstander / sykdommer i alle aldersgrupper.
Selskapet har helhetlig tilnærming til hud og helse, og skal tilby
helhetlig livsstilsveiledning. Samtidig skal virksomheten tilby
minimalt invasive hudbehandlinger hvis behov i samarbeid med ansvarlig
lege / hudlege. Norge viser høye tall med hudkreft statistikker,
hudkreft som er direkte forårsaket av UV radiasjon. Jeg ønsker å øke
bevisstheten og kunnskapen om hudhelse i samfunnet på individ og
nasjonalt nivå. Virksomheten vil i tillegg drive med salg av hudpleie
produkter.
Hudpleie og medisinske hudbehandlinger. Salg av hudpleieprodukter.
Livsstilsveiledning.
Organization
- CEO
- JS
Jurgita Sele1977
- Chairman of the board
- JS
Jurgita Sele1977
- Years since formation
- 5 years
- since May 25, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 3,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 628,812
- NOK
- Annual total result 2025
- -15,915
- NOK
- Total equity 2025
- 254,200
- NOK
Last update: May 12, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JS 1977 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
JS 1977 | Chairman | 100 % directly |
IS 1964 | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JS 1977 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 8, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
JS 1977 | Ordinary shares | 3,000 | 100 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 628,812 | 599,575 | 450,351 | 452,167 | 156,966 |
Annual Total Result | -15,915 | 62,058 | -13,138 | 115,519 | -194,323 |
Total assets | 319,101 | 295,235 | 239,847 | 296,342 | 204,300 |
Total liabilities | 64,901 | 25,120 | 31,790 | 75,146 | 98,623 |
Total equity | 254,200 | 270,115 | 208,057 | 221,196 | 105,677 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 628,812 | 599,575 | 450,351 | 452,167 | 156,966 |
Total operating costs | 644,803 | 536,168 | 463,656 | 336,684 | 351,289 |
Operating result | -15,992 | 63,407 | -13,304 | 115,483 | -194,323 |
Financial income/costs | 77 | -1,349 | 166 | 36 | 0 |
Profit before tax | -15,915 | 62,058 | -13,138 | 115,519 | -194,323 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -15,915 | 62,058 | -13,138 | 115,519 | -194,323 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 319,101 | 295,235 | 239,847 | 296,342 | 204,300 |
Total assets | 319,101 | 295,235 | 239,847 | 296,342 | 204,300 |
Short term debt | 64,901 | 25,120 | 24,500 | 37,887 | 21,384 |
Long term debt | 0 | 0 | 7,290 | 37,259 | 77,239 |
Total liabilities | 64,901 | 25,120 | 31,790 | 75,146 | 98,623 |
Contributed capital | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 |
Retained earnings | -45,800 | -29,885 | -91,943 | -78,804 | -194,323 |
Total equity | 254,200 | 270,115 | 208,057 | 221,196 | 105,677 |
Total equity and liabilities | 319,101 | 295,235 | 239,847 | 296,342 | 204,300 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises